BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 10202009)

  • 21. IFN-gamma and IFN-beta independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages.
    Hamilton TA; Bredon N; Ohmori Y; Tannenbaum CS
    J Immunol; 1989 Apr; 142(7):2325-31. PubMed ID: 2494257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-alpha beta reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase.
    Jiang H; Rummage JA; Zhou A; Chen Z; Herriot MJ; Stewart CA; Kolosov M; Leu RW
    J Immunol; 1996 Jul; 157(1):305-12. PubMed ID: 8683131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages.
    Narumi S; Tebo JM; Finke JH; Hamilton TA
    J Immunol; 1992 Jul; 149(2):529-34. PubMed ID: 1624799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon.
    Sands WA; Bulut V; Severn A; Xu D; Liew FY
    Eur J Immunol; 1994 Oct; 24(10):2345-50. PubMed ID: 7523136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-GuĂ©rin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase.
    Yoshida A; Koide Y; Uchijima M; Yoshida TO
    J Immunol; 1995 Aug; 155(4):2057-66. PubMed ID: 7543537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages.
    Chen F; Kuhn DC; Sun SC; Gaydos LJ; Demers LM
    Biochem Biophys Res Commun; 1995 Sep; 214(3):839-46. PubMed ID: 7575553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes.
    Salkowski CA; Barber SA; Detore GR; Vogel SN
    J Immunol; 1996 May; 156(9):3107-10. PubMed ID: 8617930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro.
    Sawangjaroen K; Sernia C; Curlewis JD
    J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
    Suzuki A; Kotoyori J; Oiso Y; Kozawa O
    Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic cooperation between phorbol ester and IFN-gamma for induction of nitric oxide synthesis in murine peritoneal macrophages.
    Jun CD; Choi BM; Hoon-Ryu ; Um JY; Kwak HJ; Lee BS; Paik SG; Kim HM; Chung HT
    J Immunol; 1994 Oct; 153(8):3684-90. PubMed ID: 7523501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide.
    Straub SG; Sharp GW
    J Biol Chem; 1996 Jan; 271(3):1660-8. PubMed ID: 8576167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotropic peptide (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3',5'-monophosphate and interleukin-6 secretion and cell proliferation.
    Matsumoto H; Koyama C; Sawada T; Koike K; Hirota K; Miyake A; Arimura A; Inoue K
    Endocrinology; 1993 Nov; 133(5):2150-5. PubMed ID: 8404665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages.
    Chen F; Sun SC; Kuh DC; Gaydos LJ; Demers LM
    Biochem Biophys Res Commun; 1995 Sep; 214(3):985-92. PubMed ID: 7575573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism.
    Cardinaux JR; Magistretti PJ
    J Neurosci; 1996 Feb; 16(3):919-29. PubMed ID: 8558260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophages ingest and are activated by bacterial DNA.
    Stacey KJ; Sweet MJ; Hume DA
    J Immunol; 1996 Sep; 157(5):2116-22. PubMed ID: 8757335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
    Zia H; Hida T; Jakowlew S; Birrer M; Gozes Y; Reubi JC; Fridkin M; Gozes I; Moody TW
    Cancer Res; 1996 Aug; 56(15):3486-9. PubMed ID: 8758916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.